AILEEN JOANNA ALMEDA VASQUEZ: Open Payments
NPI 1144796863 · OAKHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,794 in 162 payments from 20 companies in 2025. Trend: 2023 $1,769 · 2024 $2,156 · 2025 $2,794
Food & beverage: $2,700Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $625 |
| Madrigal Pharmaceuticals | 22 | $398 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $299 |
| Lilly USA, LLC | 16 | $268 |
| Janssen Biotech, Inc. | 14 | $255 |
| GENZYME CORPORATION | 12 | $245 |
| PFIZER INC. | 11 | $185 |
| QOL Medical, LLC | 7 | $127 |
| Aimmune Therapeutics, Inc. | 4 | $68 |
| Ardelyx, Inc. | 3 | $66 |
Products named: REZDIFFRA, DUPIXENT, ENTYVIO, OMVOH, TREMFYA, RINVOQ, SKYRIZI, Sucraid.
Industry payments across NJ — which companies pay providers there.
